Chinese battery giant CATL posts annual revenue drop ahead of Hong Kong listing

Chinese battery giant CATL posts annual revenue drop ahead of Hong Kong listing


Chinese battery giant Contemporary Amperex Technology (CATL), pictured here on April 2, 2020, broke ground on its first overseas factory in Germany in late 2019 and plans to add up to 2,000 jobs there by 2025.

Martin Schutt | picture alliance | Getty Images

China’s Contemporary Amperex Technology posted a 9.7% drop in annual revenue, a stock exchange filing showed on Friday, as a price war in the mainland electric vehicle market ensnared the world’s largest battery maker.

Revenue for the 12-month period ending December came in at 362 billion yuan ($50.01 billion), just under a LSEG mean estimate of 368.7 billion yuan. It marked the company’s first drop in yearly revenue since the company started releasing its operating figures in 2015.

Despite the annual drop in revenue, net profit went up by 15% year -over-year to 50.74 billion yuan.

The earnings come as the company is slated for a listing on the Hong Kong’s stock exchange. Reuters reported that the deal is expected to raise at least $5 billion in what would be the city’s largest initial public offering since Chinese TikTok rival Kuaishou’s $5.32 billion public offering in early 2021.

Chinese sales of electric vehicles — a key market for CATL — shifted to a higher gear last year as a mix of subsidies and consumer purchase incentives supported sales. EV sales in China jumped 40% on year to hit 11 million vehicles in 2024, according to data from U.K. research firm Rho Motion.

CATL — the world’s largest electric-vehicle battery maker, known for producing lower-cost but durable cells — counts Tesla, Volkswagen, Li Auto, NIO as key customers and enjoys a dominant 45% market share in China last year in terms of EV battery installations, according to data from China Automotive Battery Innovation Alliance.

Shenzhen-listed CATL has a market cap of 1.12 trillion yuan as of Thursday, according to data from LSEG.

In January, the U.S. Department of Defense put CATL and Chinese internet giant Tencent on its list of “Chinese Military Companies,” which would prohibit the department from procuring goods and services from these companies starting June 2026. The company has denied any engagement in military-related business and said it will work with DoD to address the “false designation.”

The company also sounded caution last month that uncertainties over tariffs were also a risk to the business given its global operation.

The battery maker has pressed ahead with investments overseas, including a battery factory in Hungary to sell to the likes of Mercedes and BMW, as well as a joint venture with automaker Stellantis to build a lithium iron phosphate battery plant in Spain.



Source

The case for more Fed rate cuts could rest on a ‘systemic overcount’ of jobs numbers
World

The case for more Fed rate cuts could rest on a ‘systemic overcount’ of jobs numbers

In the Federal Reserve’s battle between fighting inflation and limiting unemployment, the latter side carried the day Wednesday and could also have an edge heading into 2026 if labor market weakness becomes more evident through an apparent overcounting of jobs numbers. In the immediate term, worries over the employment situation meant a vote, albeit divided […]

Read More
Bessent to propose major overhaul of regulatory body created from financial crisis
World

Bessent to propose major overhaul of regulatory body created from financial crisis

U.S. Treasury Secretary Scott Bessent speaks onstage during The New York Times DealBook Summit 2025 at Jazz at Lincoln Center on December 03, 2025 in New York City. David Dee Delgado | Getty Images Entertainment | Getty Images Treasury Secretary Scott Bessent is proposing a major change in the approach to how the government approaches […]

Read More
Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial  
World

Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial  

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Thursday said its next-generation obesity drug delivered strong weight loss and reduced knee arthritis pain in a late-stage study, clearing the first of several upcoming trials on the weekly injection.  The […]

Read More